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The amino acid sequence of a newIy isolated pentapeptide, neo-kyotorphin from bovine brain was 
synthetically verified to be Thr-Ser-Lys-Tyr-Arg corresponding to the C-terminal portion of 
hemoglobin a-chain. The synthetic neo-kyotorphin showed the dose-dependent a algesia in mice which 
was approximately equal to that of Leu~nkeph~in. 
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1. INTRODUCTION 
An analgesic dipeptide, kyotorphin (Tyr-Arg), 
from bovine brain was isolated and identified in 
[1,2]. During the course of kyotorphin isolation, a 
peptide-like substance, which elicited contraction 
in the guinea pig ileum, was detected in the 
methanol-soluble fraction. This peptide-like 
substance termed KT-2 has been isolated and the 
amino acid sequence proposed. However, further 
studies suggested that KT-2 contained a peptide 
and trace of histamine [3]. Therefore, we syn- 
thesized the pentapeptide corresponding to the 
proposed amino acid sequence for chemical and 
pharmacological characterization, and found that 
the synthetic pentapeptide was identical to the 
natural compound and did not induce contraction 
in the guinea pig ileum. Here, we show that the 
amino acid sequence of this newly isolated peptide 
(neo-kyotorphin) has been synthetically verified to 
be Thr-Ser-Lys-Tyr-Arg, corresponding to the 
C-terminal portion of hemoglobin a-chain. Syn- 
thetic neo-kyotorphin exhibited an analgesic effect 
but no inhibitory effect on the electrically evoked 
contraction of guinea pig ileum. The hemoglobin 
C-terminal pentapeptide exhibits analgesic 
activity. 
2, EXPERIMENTAL 
2.1. Synthesis of peptides 
Abbreviations: Z, benzyloxycarbonyl; Z(OMe), p- 
methoxybenzyloxycarbonyl; TFA, trifluoroacetic acid; 
TOS, p-toluenesulphonyl 
The synthetic scheme is outlined in fig. 1. Thin- 
layer chromatography (TLC) was carried out on 
Merck silica gel 60 F-254 precoated plates 
(0.25 mm) in the solvent system; chloroform : me- 
thanol : water (8: 3 : 1, by vol.), lower layer (Rr’). 
High-performance thin-layer chromatography 
(HPTLC) on cellulose plate (10 x 20 cm, 0.1 mm 
thick) was carried out in the solvent system; n- 
butanol : pyridine : acetic acid : water (I 5 : 10 : 3 : 12, 
by vol.) (Rf). High-voltage paper electrophoresis 
(HVPE) was performed on Toyo no.5 1 filter paper 
at 50 V/cm for 90 min in a buffer (pH 3.6); 
pyridine : acetic acid : water (1: 10: 89, by vol.). To 
determine the relative mobility (&) of each spot, 
arginine was used as a standard. Reverse-phase 
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Z(OMe)-Lys(Z)-Tyr-Arg(Tos) 
1 
TFA 
LYE.(Z)-Tyr-Arg(Tos) 
Z(OMe)-Thr-Ser-NHNH2 
Z(OMe)-Thr-Ser-Lys(Z)-Tyr-Arg(Tos) 
1 
TFMSA-thioanisole 
Thr-Ser-Lys-Tyr-Arg 
Fig. 1. Synthetic scheme of neo-kyotorphin. 
high-performance liquid chromatography (HPLC) 
was carried out using Yanaco Model L-2000 with 
a Cosmosil SC18 column (15 cm x 4.6 mm) in a 
solvent system of 0.1 M KH2P04 (pH 3.1), con- 
taining 2% acetonitrile, at 0.7 ml/min. 
2.1.1. Z(OMe)-Lys(Z)-Tyr-OEt 
Z(OMe)-Lys(Z) and Tyr-OEt were condensed 
using dicyclohexylcarbodiimide in dimethylfor- 
mamide (DMF). After the coupling reaction for 
48 h at room temperature, Z(OMe)-Lys(Z)-Tyr- 
OEt was obtained in 80% yield; m.p. 77-78’C; Rf’ 
0.70; satisfactory elemental analysis for 
C&I41W%. 
2.1.2. Z(OMe)-Lys(Z)-Tyr-NHNH2 
Z(OMe)-Lys(Z)-Tyr-OEt in a mixture of 
methanol and DMF was treated with hydrazine 
hydrate at room temperature overnight. Z(OMe)- 
Lys(Z)-Tyr-NHNH2 was obtained in 84% yield; 
m.p. 115-l 18’C; Rf’ 0.68; satisfactory elemental 
andySiS for C32H390gN~. 
2.1.3. Z(OMe)-Lys(Z)-Tyr-Arg(Tos) 
Arg(Tos) was condensed with Z(OMe)- 
Lys(Z)-Tyr-NHNHz by the azide method in DMF. 
After the coupling reaction for 48 h at 4”C, 
Z(OMe)-Lys(Z)-Tyr-Arg(Tos) was obtained in 
89% yield; m.p. 115-l 18°C; Rf’ 0.39; satisfactory 
elemental analysis for C~SHSSO~~N~S. HzO. 
2.1.4. Z(OMe)-Thr-Ser-Lys(Z)-Tyr-Arg(Tos) 
Z(OMe)-Lys(Z)-Tyr-Arg(Tos) was deblocked 
with TFA-anisole, and the resulting 
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Lys(Z)-Tyr-Arg(Tos) was condensed with 
Z(OMe)-Thr-Ser-NHNH2 by the azide method in 
DMF. After the coupling reaction for 48 h at 4”C, 
the product was purified by silica gel column 
chromatography using the solvent system; 
chloroform-methanol-water (8 : 3 : 1, by vol., 
lower layer). Yield 76%; m.p. 116-119°C: Rf’ 
0.22; satisfactory elemental analysis for 
Cs2Ha7016N9S - HzO; satisfactory amino acid 
analysis of an acid hydrolysate. 
2.1 S. Thr-Ser-Lys-Tyr-Arg (neo-kyotorphin) 
Z(OMe)-Thr-Ser-Lys(Z)-Tyr-Arg(Tos) was 
deblocked with TFA-trifluoromethanesulphonic 
acid (TFMSA)-thioanisole-o-cresol at room 
temperature for 3 h, and the deblocked material 
was purified by column chromatography on 
Sephadex G-10 (3% acetic acid) and 
carboxymethyl-cellulose (a linear gradient from 
water to 1 M ammonium acetate). A white fluffy 
powder was obtained by the lyophilization in 41% 
yield; Rf2 0.43; R, 0.91; HPLC retention time 
11 min; satisfactory elemental analysis for 
C2gH4709N9 - 2 CH~COIH - 3 H20; satisfactory 
amino acid analyses of an acid hydrolysate and an 
enzymatic (leucine aminopeptidase) hydrolysate; 
[cY]~ - 21.7” (c = 1.2, 3% AcOH). 
2.2. Bioassay 
Analgesic effect of synthetic peptide was ex- 
amined using the intracisternal injection technique 
in mice as in [4]. 
Ileal contracting activity was determined using 
the isolated guinea pig ileum as in [5]. Inhibitory 
effect on the electrically evoked contraction of the 
isolated guinea pig ileum was determined as in [6]. 
3. RESULTS AND DISCUSSION 
Since diphenhydramine pretreatment inhibited 
the contraction of isolated guinea pig ileum induc- 
ed by KT-2, we assumed that the contraction of 
guinea pig ileum might be induced by histamine in- 
cluded in the peptide sample [3]. For elucidation, 
we synthesized the pentapeptide corresponding to 
the proposed amino acid sequence by the conven- 
tional solution method. In the present synthesis, 
we employed the TFMSA-thioanisole deprotec- 
tion system which could completely cleave the fl- 
tosyl group [7]. The obtained sample was checked 
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Fig.2. High-voltage paper electrophoresis: (A) natural 
neo-kyotorphin; (B) natural and synthetic neo- 
kyotorphin (A + C); (C) synthetic neo-kyotorphin; (D) 
arginine as a standard. 
by amino acid analyses, elemental analysis, 
HPTLC, HVPE, and HPLC, and was indicated to 
be the desired homogeneous pentapeptide. 
Synthetic pentapeptide was identical to the 
natural one on three different chromatographic 
systems; i.e., HPTLC (Rf2 = 0.43), HVPE (R,,, = 
0.91) (fig.2) and HPLC (11 min), These verified 
that the structure of this peptide named neo- 
kyotorphin was Thr-Ser-Lys-Tyr-Arg. 
Synthetic neo-kyotorphin exhibited no contrac- 
ting effect on the isolated guinea pig ileum in a 
dose of 2 x lo-’ M. The electrophoretogram of 
KT-2 was extracted with 0.5 M acetic acid in the 
position in which R, was identical to that of the 
authentic histamine. The extracted material induc- 
ed contraction in the isolated guinea pig ileum, and 
diphenhydramine pretreatment inhibited this ef- 
fect. Thus, it became clear that KT-2 contained 
both neo-kyotorphin and a trace of histamine. 
Synthetic neo-kyotorphin exhibited a dose- 
dependent analgesic effect after intracisternal in- 
jection in mice. The EDSO value was 195 nmol/ 
mouse. Analgesic activity of neo-kyotorphin is 
5.6”times lower than that of kyotorphin (ED50 = 
34.7 nmob’mouse), and approximately equal to 
that of Leu-enkephalin (EDSO = 233 nmol/mouse) 
[2,4,8]. However, synthetic neo-kyotorphin had no 
inhibitory effect on the electrically evoked contrac- 
tion of the isolated guinea pig ileum in a dose of 
1.3 x 1O-4 M. 
The peptide bond between Lys3 and Tyr4 in 
neo-kyotorphin could be cleaved by trypsin-like 
peptidase in the brain and Tyr-Arg (kyotorphin) 
was released from neo-kyotorphin [3]. Thr-Ser- 
Lys-NH2 corresponding to the N-terminal portion 
of neo-kyotorphin (scheme 1) had been isolated 
Scheme 1 
137 141 hemoglobin 
-----Val-Leu-Thr-Ser-Lys-Tyr-Arg @-chain 
Thr-Ser-Lys-Tyr-Arg neo-kyotorphin 
Tyr-Arg kyotorphin 
Thr-Ser-Lys-NH2 
antireproductive 
peptide 
Amino acid sequences of neo-kyotorphin and related 
peptides 
from the bovine pineal glands and shown to have 
antigonadotropic activity [9]. Moreover, the 
amino acid sequence of neo-kyotorphin is identical 
to that of the C-terminal portion of human and 
bovine hemoglobin cu-chain [lo,1 11. The 
hemoglobin C-terminal peptides exhibit biological 
activities, but the relationships between these pep- 
tides remain to be clarified. 
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